期刊文献+

BACE1抑制剂分子水平高通量筛选体系的建立 被引量:3

Establishment of high-throughput screening system for BACE1 inhibitors in vitro
下载PDF
导出
摘要 目的建立体外分子水平β-分泌酶(BACE1)抑制剂高通量筛选体系。方法采用均相时间分辨荧光法(HTRF),通过优化反应时间、酶浓度、检测仪器等实验条件,建立BACE1抑制剂高通量筛选体系,根据待测样品对BACE1活性抑制程度筛选其抑制剂。结果采用HTRF法建立了BACE1抑制剂高通量筛选体系,其中反应时间确定为6h、BACE1浓度为670U/L,采用VICTOR3酶标仪测得信噪比为649.6,信背比为44.6,Z′因子为0.91,变异系数小于10%,并筛选到一系列IC50小于10-6mol/L的化合物。结论采用HTRF法建立的BACE1抑制剂筛选体系灵敏度高、特异性和稳定性好,可用于BACE1抑制剂的高通量筛选。 Objective To establish the high-throughput screening system for β-secretase(β-site amyloid precursor protein cleaving enzyme 1,BACE1)inhibitors in vitro.Methods Using the homogeneous time-resolved fluorescence(HTRF) technique to establish a high-throughput screening system for BACE1 inhibitors according to the extent that test compounds inhibited BACE1 activity by optimizing the incubation time,enzyme concentration and the detector.Results A high-throughput screening system for BACE1 inhibitors based on HTRF methods was established.The incubation time was 6 h,the BACE1 concentration is 670 U/L.According to the detector of VICTOR3,the signal-to-noise(S/N) ratio reached 649.6,while the signal-to-background(S/B) ratio and Z' factor were 44.6 and 0.91,respectively.The coefficient of variation(CV) was much lower than 10%.Using this method,the inhibitors with IC5010-6mol/L could be screened out.Conclusion The high-throughput screening system based on HTRF Could assure a high sensitivity,specificity and stability,which could be used to high-through put screening for the BACE1 inhibitors.
出处 《国际药学研究杂志》 CAS 2010年第4期302-309,共8页 Journal of International Pharmaceutical Research
基金 国家科技重大专项--综合性新药研究开发技术大平台资助项目(2009zx09502-017) 国家自然科学基金资助项目(90709012 30772562 30973541) 国家重点基础研究发展计划(973计划)资助项目(2004CB518907) 国家高技术研究与发展计划(863计划)资助项目(2008AA02Z423)
关键词 Β分泌酶 BACE1抑制剂 均相时间分辨荧光 高通量筛选 Z′因子 β-secretase BACE1 inhibitor homogeneous time-resolved fluorescence high-throughput screening Z' factor
  • 相关文献

参考文献23

  • 1Sabbagh MN,Farlow MR,Relkin N,et al.Do cholinergic therapies have disease-modifying effects in Alzheimcr's disease?[J].Alzheimers Dement,2006,2(2):118-125.
  • 2Bullock R,dengiz A.Cognitive performance in patients with Alzheimer's Disease receiving cholineslerase inhibitors for up to 5 years[J].Int J Clin Pract,2005,59(7):817-822.
  • 3Cai H,Wang Y,McCarthy D,et al.BACE1 is the major β-secretase for generation of Aβ peptides by neurons[J].Nat Neurosci,2001,4 (3):233-234.
  • 4Li R,Lindholm K,Yang LB,et al.Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients[J].Proc Natl Acad Sci USA,2004,101(10):3632-3637.
  • 5Pope AJ.Introduction LANCETM vs.HTRF technologies (or vice versa)[J].J Biomol Screen,1999,4(6):301-302.
  • 6Boute N,Jockers R,Issad T.The use of resonance energy transfer in high-throughput screening:BRET versus FRET[J].Trends Pharmacol Sci,2002,23(8):351-354.
  • 7Kolb A,Neumann K,Mathis G.New developments in HTS technology[J].Pharm Manuf Int,1996,31:31-39.
  • 8Auer M,Moore KJ,Meyer-Almes FJ,et al.Fluorescence correlation spectroscopy:lead discovery by miniaturized HTS[J].Drug Discov Today,1998,3(10):457-465.
  • 9Hess ST,Huang SH,Heikal AA,et al.Biological and chemical applications of fluorescence correlation spectroscopy:A review[J].Biochemistry,2002,41(3):697-705.
  • 10Zhang JH,Chung TD,Oldenburg KR.A simple statistical parameter for use in evaluation and validation of high throughput screening assays[J].J Biomol Screen,1999,4(2):67-73.

同被引文献20

  • 1魏其艳,罗应刚,张国林.菲醌的生物活性[J].天然产物研究与开发,2005,17(5):665-668. 被引量:2
  • 2Uryu K,Chen XH,Martinez D,et al. Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans.Exp Neurol,2007,208:185-192.
  • 3Mannix RC,Zhang J,Park J,et al.Detrimental effect of genetic inhibition of B-Site App-cleaving enzyme I on functional outcome after controlled cortical impact in young adult mice.J Neurotrauma,2011,28:1855-1861.
  • 4Goedert M, Spillantini MG.A century of Alzheimer's disease.Science,2006,314 (5800):777-781.
  • 5Lindhohm D,Wootz H,Korhonen L.ER stress aud neurodegenerative diseases.Cell Death Differ,2006,13:385-392.
  • 6Blasko I,Beer R,Bigl M,et al.Experimental traumatic brain injury in rats stimulates the expression,production and activity of Alzheimer's disease b-secretase (BACE-1).J Neural Transm,2004,111:523-536.
  • 7Truettner JS,Suzuki T,Dietrich WD.The effect of therapeutic hypothermia on the expression of inflammatory response genes following moderate traumatic brain injury in the rat. Brain Res Mol Brain Res,2005,138:124-134.
  • 8Teseo G,Koh YH,Kang EL.,el al.Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity.Neuron,2007,54:721-737.
  • 9Huang T.Solano J,He D,et al.Traumatic injury activates MAP Kinases in astrocytes: mechanisms of hypothermia and hyperthermia.J Neurotrauma,2009.26:1535-1545.
  • 10Loane DJ,Pocivavsek A,Mousse CE.et al.Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury.Nat Med,2009,15:377-379.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部